After the drug’s local license holder called for a brief pause in new patient starts last week, doctors in Japan can once ...

Kissei Pharmaceutical has revised a package insert in Japan for Amgen's rare immune-disease drug Tavneos, saying that serious liver dysfunction could occur. The Japanese pharmaceutical company said ...

Japan's health ministry on Thursday ordered Kissei Pharmaceutical Co. to add a warning to the package insert of Tavneos, a drug for vasculitis, or blood vessel inflammation, after the deaths of 20 ...

WASHINGTON D.C. —The U.S. Food and Drug Administration is mandating safety changes to opioid pain medication labels, a move officials say will better warn patients and prescribers about the risks of ...

Kissei Pharmaceutical Co. has announced that 20 patients were reported to have died after receiving Tavneos, a vasculitis drug sold by the firm in Japan. According to the company and other sources, ...

Twenty patients who took Tavneos, a drug for blood vessel inflammation, later died after developing liver dysfunction.